Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast
Sign Up to like & getrecommendations! Published in 2017 at "International Urology and Nephrology"
DOI: 10.1007/s11255-017-1671-2
Abstract: PurposeTo prove that phosphodiesterase type-4 inhibitors could potentially treat obesity-associated overactive bladder through modulation of the systemic inflammatory response.MethodsIn this 12-week study, 90 female Sprague–Dawley rats were divided into three groups: (1) vehicle-treated normal diet… read more here.
Keywords: phosphodiesterase type; treatment; bladder; associated overactive ... See more keywords